comparemela.com

Latest Breaking News On - Strides pharma science ltd - Page 1 : comparemela.com

Strides receives USFDA approval for Sucralfate oral suspension; stocks move up

Strides Pharma gains 0.76% as USFDA approves Sucralfate Oral Suspension, expanding product portfolio and market reach.

Strides pharma science ltdStrides pharma global pte ltdUnited states food drug administrationUnited states foodDrug administrationSucralfate oral suspensionOral suspensionReference listed drugChestnut ridge

Strides Pharma Reports Net Profit Of ₹10 44 Cr In Q4FY24

Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.

Aditya kumarBadree komandurSurabhi loshaliBarun kumarStrides pharma science ltd onBusiness developmentStrides pharma science ltdExecutive chairpersonManaging director arun kumarExecutive director financeStrides pharma scienceVice presidentExecutive directorAvikesh kumarEnd marketsInvestor relations officer

Strides Pharma Records Q4 Profit, Announces Major Leadership Rejig

Strides Pharma Science Ltd reported a consolidated net profit of Rs 10.44 crore for Q4 ending March 2024, reversing a net loss of Rs 13.79 crore a year ago. The company also announced significant top management changes and achieved its highest-ever annual revenue, driven by growth in the US market.

Badree komandurBarun kumarSurabhi loshaliAditya kumarStrides pharma science ltd onBusiness developmentStrides pharma science ltdExecutive chairpersonManaging director arun kumarExecutive director financeStrides pharma scienceVice presidentExecutive directorAvikesh kumarEnd marketsInvestor relations officer

Open High Low Scanner (OHL Scanner)

This open high low scanner or OHL Scanner uses the popular open high low same trading strategy to find profitable stocks from NSE.

Uttar pradeshIndia generalStockmaniacs indrajit mukherjeeTorrent power ltdMulti commodity exchangeLife insurance company ltdZydus lifesciences ltdIndian railway ctrngTata consultancy services ltdKotak mahindra bank ltd fully paid ordIntellect design arena ltdInfo edge india ltdLt technology services ltdHindalco industries ltdPidilite industriesAditya birla capital ltd

HIV Drugs Market size is set to grow by USD 10 47 billion from 2023-2027, AbbVie Inc , Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd , and more to emerge as Some of the Key Vendors, Technavio

/PRNewswire/ The global HIV drugs market size is estimated to grow by USD 10477.51 mn from 2023 to 2027, according to Technavio. The market is estimated to.

United statesUnited kingdomJesse maidaGilead sciences incBoehringer ingelheim international gmbStrides pharma science ltdMacleods pharmaceuticals ltdAspen pharmacare holdings ltdTechnavio researchAbbvie incCipla ltdViatris incBristol myers squibb coGlaxosmithkline plcHetero labs ltdEmcure pharmaceuticals ltd

vimarsana © 2020. All Rights Reserved.